Merck KGaA reaffirmed its strong performance in the healthcare sector in its FY 2024 earnings report, but provided little additional information on ongoing acquisition talks with SpringWorks ...

My name is Florian Schraeder, I'm Head of Investor Relation at Merck. I'm delighted to be joined by Belen Garijo, Group CEO; as well as Helene von Roeder, Group CFO. For the Q&A part of this call ...

0650 ET – Merck KGaA anticipates its research and development costs will normalize to industry-peer levels as its pipeline advances and recent deals mature, Chief Executive Officer Belen Garijo ...

Find insight on Merck KGaA, Oceania Healthcare and more in the latest Market Talks covering the health care sector.

The stock rose as much as 3.5%, erasing its losses for the year. The Darmstadt, Germany-based company is unrelated to US-based Merck & Co. Chief Executive Officer Belen Garijo returned the company to ...

"We are ideally positioned to benefit from global macro trends such as complex biologics, novel modalities, and semiconductors for the AI era," Merck Chief Executive Belen Garijo said. The company ...

That diversified model makes it a small player in pharma than many of its peers, but new chief executive Belén Garijo has made it clear her ambition is to grow that side of the business through ...

“This agreement is another illustration of how we aim to enrich our discovery engine with strategic technology-focused collaborations,” said Belén Garijo, member of the executive board and CE ...

During a 6 March press call, Merck KGaA’s CEO Belén Garijo stated that there “is very little that we can say at this time,” regarding the ongoing talks. A successful acquisition would provide Merck ...